Back to trial details

Intake questionnaire

A Study of Vedolizumab Intravenous (IV) and Adalimumab or Vedolizumab and Ustekinumab in Adults With Crohn's Disease

Applying to University of Utah Health · Salt Lake City, Utah

Answer a few short questions to share with the research team.

0 of 3 answered

1. Are you between 18 and 70 years old?
2. Have you been diagnosed with Crohn's Disease?
3. Are you able to travel to Salt Lake City for study visits?